PATENT CLAIM ANALYSIS

Application Number: 15977572
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "001300"]

Abstract:
The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.

Claim (Index 35):
The conjugate of  claim 32 , wherein the at least three amino acids are in a D-configuration.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 1.72727
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14443212', '15245505', '15606913', '12530952', '15959110']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7465513577028166
- 35 USC 102 Novelty (BERT): 0.5421781276807511
- Combined Prediction Score: 0.7261140347006101
- Mean Citation Score: 320.46455
- Max Citation Score: 390.5377
- Similarity Product: 238.51443666481373

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test